PETER LOUIS GEHLBACH

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc PPAR-alpha Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration
    Marisol del V Cano
    The Wilmer Ophthalmological Institute, School of Medicine, Johns Hopkins University, Baltimore, MD 21287 9278, USA
    PPAR Res 2008:821592. 2008
  2. pmc Statins for age-related macular degeneration
    Peter Gehlbach
    Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Cochrane Database Syst Rev 3:CD006927. 2012

Research Grants

Collaborators

  • Marisol del V Cano

Detail Information

Publications2

  1. pmc PPAR-alpha Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration
    Marisol del V Cano
    The Wilmer Ophthalmological Institute, School of Medicine, Johns Hopkins University, Baltimore, MD 21287 9278, USA
    PPAR Res 2008:821592. 2008
    ..This review examines current literature for potential roles of PPAR-alpha in the pathogenesis and potential treatment of AMD with emphasis on prevention and treatment of wet AMD...
  2. pmc Statins for age-related macular degeneration
    Peter Gehlbach
    Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Cochrane Database Syst Rev 3:CD006927. 2012
    ..Recent epidemiologic, genetic and pathological evidence has shown AMD shares a number of risk factors with atherosclerosis, leading to the hypothesis that statins may exert protective effects in AMD...

Research Grants1

  1. Treatment of Ocular Neovascularization by Inhibitors
    Peter Gehlbach; Fiscal Year: 2005
    ..It will also provide me with clinical training to eventually translate the knowledge into new treatments for patients. ..